Effect of carvedilol vs metoprolol succinate on mortality in heart failure with reduced ejection fraction
American Heart Journal Jan 24, 2018
Ajam T, et al. - Physicians designed this study to compare the efficacy of carvedilol vs metoprolol succinate on mortality in heart failure with reduced ejection fraction (HFrEF). In comparison with metoprolol succinate, carvedilol taking HFrEF patients reported improved survival.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
